344 related articles for article (PubMed ID: 16428080)
1. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
3. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
[TBL] [Abstract][Full Text] [Related]
4. Renal injury induced in alloxan diabetic rats. Role of Mycophenolate Mofetil as therapeutic agent.
Elseweidy MM; Elswefy SE; Ali AE; Shawky M
Pathol Res Pract; 2014 Dec; 210(12):979-84. PubMed ID: 24939145
[TBL] [Abstract][Full Text] [Related]
5. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H
Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067
[TBL] [Abstract][Full Text] [Related]
6. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats.
Reddi AS; Bollineni JS
Kidney Int; 2001 Apr; 59(4):1342-53. PubMed ID: 11260395
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats.
Qi XM; Wu GZ; Wu YG; Lin H; Shen JJ; Lin SY
Nephron Exp Nephrol; 2006; 104(4):e147-57. PubMed ID: 16902319
[TBL] [Abstract][Full Text] [Related]
8. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.
Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Hyodo N; Suzuki S; Miura S
Nephrol Dial Transplant; 2005 Aug; 20(8):1573-81. PubMed ID: 15905195
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats.
Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z
Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.
Utimura R; Fujihara CK; Mattar AL; Malheiros DM; Noronha IL; Zatz R
Kidney Int; 2003 Jan; 63(1):209-16. PubMed ID: 12472785
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Yuan J; Jia R; Bao Y
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
[TBL] [Abstract][Full Text] [Related]
12. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
[TBL] [Abstract][Full Text] [Related]
13. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
Wang F; Li M; Cheng L; Zhang T; Hu J; Cao M; Zhao J; Guo R; Gao L; Zhang X
Life Sci; 2008 Dec; 83(25-26):828-35. PubMed ID: 18983856
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C beta inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats.
Wu Y; Wu G; Qi X; Lin H; Qian H; Shen J; Lin S
J Pharmacol Sci; 2006 Aug; 101(4):335-43. PubMed ID: 16891764
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes.
Arellano-Buendía AS; Tostado-González M; García-Arroyo FE; Cristóbal-García M; Loredo-Mendoza ML; Tapia E; Sánchez-Lozada LG; Osorio-Alonso H
Oxid Med Cell Longev; 2016; 2016():4693801. PubMed ID: 26955430
[TBL] [Abstract][Full Text] [Related]
16. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy.
Wu Y; Dong J; Yuan L; Liang C; Ren K; Zhang W; Fang F; Shen J
Cytokine; 2008 Oct; 44(1):85-91. PubMed ID: 18725182
[TBL] [Abstract][Full Text] [Related]
17. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
[TBL] [Abstract][Full Text] [Related]
18. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats.
Wu X; Zha D; Xiang G; Zhang B; Xiao SY; Jia R
Cytokine; 2006 Dec; 36(5-6):229-36. PubMed ID: 17337203
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice.
Ouyang J; Hu G; Wen Y; Zhang X
Transpl Immunol; 2010 Feb; 22(3-4):184-90. PubMed ID: 20045460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]